What happened
Green Lifescience updated a previously disclosed supply contract with UPL Limited, now worth US$6.61M, about 41.18% of its recent annual revenue, running through Jun 2026.
For context, this single contract equals about 41.18% of the company's most recent annual revenue.
| Counterparty | UPL Limited |
|---|---|
| Contract value | US$6.61M |
| vs. recent revenue | 41.18% |
| Through | Jun 2026 (from Nov 2025) |
| Filed | 2026-06-30, [Amended] Supply contract signed |
| Source | DART rcept 20260630901605 → open original filing |
Source: DART. Information only, not investment advice.